Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial
- DOI
- 10.1016/j.ahj.2026.107545
- Published
- 2026-12
- Container
- American Heart Journal
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2026.107545,
title = {Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial},
author = {Karla Santo and Eduardo Martins and Gisele S. Silva and Patricia O. Guimarães and Caio A.M. Tavares and João Brainer and Frederico Monfardini and Josué Nieri and Silvia R.L. Assis and João S. Felício and Fábio S. Silveira and Audes D.M. Feitosa and Miguel N. Hissa and Dario C. Sobral-Filho and José F. Vilela-Martin and Elizabeth E.S. Cestario and Juan C. Yugar-Toledo and Marcelo C. Batista and Luiz Turatti and Andrea A. Brandão and Weimar S. Barroso and Andrei C. Sposito and Luciano F. Drager and Luiz A. Bortolotto and Sandra C. Fuchs and Marcelo Franken and Pedro A. Lemos and Raul D. Santos and Anthony Rodgers and Paul K. Whelton and Flavio D. Fuchs and Otavio Berwanger},
year = {2026},
journal = {American Heart Journal},
doi = {10.1016/j.ahj.2026.107545},
url = {https://doi.org/10.1016/j.ahj.2026.107545}
}RIS
TY - JOUR TI - Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial AU - Karla Santo AU - Eduardo Martins AU - Gisele S. Silva AU - Patricia O. Guimarães AU - Caio A.M. Tavares AU - João Brainer AU - Frederico Monfardini AU - Josué Nieri AU - Silvia R.L. Assis AU - João S. Felício AU - Fábio S. Silveira AU - Audes D.M. Feitosa AU - Miguel N. Hissa AU - Dario C. Sobral-Filho AU - José F. Vilela-Martin AU - Elizabeth E.S. Cestario AU - Juan C. Yugar-Toledo AU - Marcelo C. Batista AU - Luiz Turatti AU - Andrea A. Brandão AU - Weimar S. Barroso AU - Andrei C. Sposito AU - Luciano F. Drager AU - Luiz A. Bortolotto AU - Sandra C. Fuchs AU - Marcelo Franken AU - Pedro A. Lemos AU - Raul D. Santos AU - Anthony Rodgers AU - Paul K. Whelton AU - Flavio D. Fuchs AU - Otavio Berwanger PY - 2026 JO - American Heart Journal DO - 10.1016/j.ahj.2026.107545 UR - https://doi.org/10.1016/j.ahj.2026.107545 ER -
APA
Santo, K., Martins, E., Silva, G. S., Guimarães, P. O., Tavares, C. A., Brainer, J., Monfardini, F., Nieri, J., Assis, S. R., Felício, J. S., Silveira, F. S., Feitosa, A. D., Hissa, M. N., Sobral-Filho, D. C., Vilela-Martin, J. F., Cestario, E. E., Yugar-Toledo, J. C., Batista, M. C., Turatti, L., Brandão, A. A., Barroso, W. S., Sposito, A. C., Drager, L. F., Bortolotto, L. A., Fuchs, S. C., Franken, M., Lemos, P. A., Santos, R. D., Rodgers, A., Whelton, P. K., Fuchs, F. D., & Berwanger, O. (2026). Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial. American Heart Journal. https://doi.org/10.1016/j.ahj.2026.107545
Source records
- crossref · retrieved 2026-09-26T14:31:19.058Z